BamSEC and AlphaSense Join Forces
Learn More

PharmaCyte Biotech Inc. – Material Contracts

NASDAQ: PMCB    
Share price (3/25/26): $0.76    
Market cap (3/25/26): $8.170 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 8-K 17 pages PharmaCyte Biotech, Inc. 2022 Equity Incentive Plan, as Amended
12/34/56
EX-10.4
from 8-K 22 pages Registration Rights Agreement
12/34/56
EX-10.3
from 8-K 23 pages Tnf Pharmaceuticals, Inc. Warrant to Purchase Common Stock
12/34/56
EX-10.2
from 8-K 38 pages Certificate of Designations of Series H Convertible Preferred Stock of Tnf Pharmaceuticals, Inc
12/34/56
EX-10.1
from 8-K 37 pages Securities Purchase Agreement
12/34/56
EX-10.3
from 8-K 12 pages A. Appointment of Gpn
12/34/56
EX-10.2
from 8-K 22 pages Form of Registration Rights Agreement
12/34/56
EX-10.1
from 8-K 39 pages Form of Securities Purchase Agreement
12/34/56
EX-10.43
from 10-K 12 pages Executive Compensation Agreement
12/34/56
EX-10.5
from 8-K 20 pages Registration Rights Agreement
12/34/56
EX-10.4
from 8-K 23 pages Form of Warrant Mymd Pharmaceuticals, Inc. Warrant to Purchase Common Stock
12/34/56
EX-10.3
from 8-K 22 pages Form of Warrant Mymd Pharmaceuticals, Inc. Warrant to Purchase Common Stock
12/34/56
EX-10.2
from 8-K 37 pages Certificate of Designations of Series G Convertible Preferred Stock of Mymd Pharmaceuticals, Inc
12/34/56
EX-10.1
from 8-K 38 pages Securities Purchase Agreement
12/34/56
EX-10.4
from 8-K 12 pages Collaboration Agreement
12/34/56
EX-10.3
from 8-K 16 pages Registration Rights Agreement
12/34/56
EX-10.2
from 8-K 31 pages Form of Senior Unsecured Convertible Note
12/34/56
EX-10.1
from 8-K 36 pages Securities Purchase Agreement
12/34/56
EX-10.3
from 8-K 12 pages A. Appointment of Katalyst
12/34/56
EX-10.2
from 8-K 22 pages Registration Rights Agreement
12/34/56